BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33802239)

  • 41. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X; Wang JS; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of cytotoxic activity of Schisandra chinensis lignans.
    Smejkal K; Slapetová T; Krmenčík P; Babula P; Dall'Acqua S; Innocenti G; Vančo J; Casarin E; Carrara M; Kalvarová K; Dvorská M; Slanina J; Kramářová E; Julínek O; Urbanová M
    Planta Med; 2010 Oct; 76(15):1672-7. PubMed ID: 20458670
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 44. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail
    Valicherla GR; Mishra A; Lenkalapelly S; Jillela B; Francis FM; Rajagopalan L; Srivastava P
    Xenobiotica; 2019 Dec; 49(12):1396-1402. PubMed ID: 30747554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
    Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time- and NADPH-Dependent Inhibition on CYP3A by Gomisin A and the Pharmacokinetic Interactions between Gomisin A and Cyclophosphamide in Rats.
    Zhai J; Zhang F; Gao S; Chen L; Feng G; Yin J; Chen W
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28786954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily.
    Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T
    Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wuweizisu C from Schisandra chinensis decreases membrane potential in C6 glioma cells.
    Choi YW; Kim K; Jo JY; Kim HL; Lee YJ; Shin WJ; Sacket SJ; Han M; Im DS
    Acta Pharmacol Sin; 2008 Sep; 29(9):1006-12. PubMed ID: 18718168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
    McCormick A; Swaisland H; Reddy VP; Learoyd M; Scarfe G
    Xenobiotica; 2018 Jun; 48(6):555-564. PubMed ID: 28657402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.
    Lang J; Li W; Zhao J; Wang K; Chen D
    Xenobiotica; 2017 Oct; 47(10):849-855. PubMed ID: 27819189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of Schisandra chinensis (Wuweizi) constituents on the activity of hepatic microsomal CYP450 isozymes in rats detected by using a cocktail probe substrates method].
    Wang BL; Hu JP; Sheng L; Li Y
    Yao Xue Xue Bao; 2011 Aug; 46(8):922-7. PubMed ID: 22007516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro assessment of cytochrome P450 inhibition and induction potential of tanespimycin and its major metabolite, 17-amino-17-demethoxygeldanamycin.
    Gan J; Liu-Kreyche P; Humphreys WG
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):51-6. PubMed ID: 21594721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
    Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Li M; Liu X; Wang Y; Ju X
    Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
    Baldwin SJ; Clarke SE; Chenery RJ
    Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
    Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
    Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes.
    Liu L; Sun S; Rui H; Li X
    Pharm Biol; 2017 Dec; 55(1):1868-1874. PubMed ID: 28614988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
    He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
    Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method.
    Kang D; Geng T; Lian Y; Li Y; Ding G; Huang W; Ma S; Wang Z; Ma Z; Xiao W
    Biomed Chromatogr; 2017 Jul; 31(7):. PubMed ID: 27891633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.